Tuesday, April 20, 1999
TRISTATE MARKET SPOTLIGHT
Eli Lilly profits up; Prozac sales down
Eli Lilly & Co. Monday said first-quarter profit rose 12 percent even as sales declined for its biggest drug, the antidepressant Prozac.
Lilly shares ended the day down $9.433/4 at $72.871/2.
Profit from operations rose to $588.8 million, or 53 cents, from $524.4 million, or 46 cents, as sales of Lilly's schizophrenia drug Zyprexa and other newer pills helped make up for a 4 percent drop in Prozac. Results matched the average estimate of analysts polled by First Call Corp.
Sales rose 8.1 percent to $2.26 billion.
EU concedes on banana rules
Convergys' Wiztec bid may be low
Comair to break ground on corporate building
Tent-renter branching out
GM-Toyota link start of merger?
Nasdaq plunges on tech sell-off
TRISTATE BUSINESS SUMMARY
INDUSTRY NOTES: BANKING
TRISTATE MARKET SPOTLIGHT
